KaloBios Raises $20M

Palo Alto-based Kalobios Pharmaceuticals said Monday that the firm has raised $20M in a Series C venture round. The firm, which is developing therapeutic antibodies, said that the round was led by Lehman Brothers. Other investors include previous investors MPM Capital, Sofinnova Ventures, Alloy Ventures, 5AM Ventures, Singapore Bioinnovations Pte., and Lotus BioScience Ventures. The firm said that the financing will go towards advancing clinical development of the firm's two therapeutic candidates. More information »